Abstract
Background: Diabetes mellitus (DM) is a complex metabolic disorder that alters the glucose status of the human body. There has been a steady increase in the prevalence of DM in the past few decades leading to macro-and microvascular complications. There has been mounting evidence suggesting that inammation plays a role in the pathophysiology of DM. Methods: Asingle centre prospective study was conducted on 50 consecutive patients with de novo or prior Type-2 DM (T2DM) history between JANUARY 2021 to OCTOBER 2021. CRP and HbA1c samples were taken at the start of the study and were retaken after 12 weeks of pharmacotherapy and lifestyle modication. The relationship between CRPand HbA1c was analysed. Results: The mean HbA1c and CRP for the initial 50 participants were 9.6500 ± 1.8816 and 1.1520 ± 0.9984, respectively. At the 12th-week follow up, the mean HbA1c fell to 7.3952 ± 1.3155 (P<0.05), and the mean CRP was reduced to 0.2857 ± 0.5237 (P<0.05). Furthermore, the rise in HbA1c was correlated with a statistically signicant rise in CRP. Conclusion: This study establishes a positive correlation between serum CRP and HbA1c. Improving glycemic control can help reduce the risk of adverse events associated with sustained inammation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
